News

In the News
More
Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy.
7 August 2019
Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy. Read More
How to spot the hidden gem investment funds
29 June 2019
How to spot the hidden gem investment funds Read More
CardioFocus lands $55M in funding for product launches
28 May 2019
CardioFocus lands $55M in funding for product launches Read More
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
20 May 2019
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S. Read More
Press Releases
More
SV Health Investors Announces Licensing and Research Collaboration between Sitryx and Lilly to Discover and Develop New Immunometabolic Medicines
31 March 2020
SV Health Investors Announces Licensing and Research Collaboration between Sitryx and Lilly to Discover and Develop New Immunometabolic Medicines Read More
Bardy Diagnostics™ Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine
25 March 2020
Bardy Diagnostics™ Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine Read More
DDF portfolio company AstronauTx secures investment from UCL Technology Fund to further new approaches to dementia therapeutics
24 March 2020
DDF portfolio company AstronauTx secures investment from UCL Technology Fund to further new approaches to dementia therapeutics Read More
COVID-19 Pulse from Evidation
18 March 2020
COVID-19 Pulse from Evidation Read More
Press Contacts
Events
More

View all events